Gauss A, Jahn S K, Eberhart L H J, Stahl W, Rockemann M, Georgieff M, Wagner F, Meierhenrich R
Klinik für Anästhesiologie, Universitätsklinikum Ulm, Deutschland.
Anaesthesist. 2011 Oct;60(10):950-62. doi: 10.1007/s00101-011-1941-9.
Thoracic epidural analgesia (EDA) is thought to provide cardioprotective effects in patients undergoing noncardiac surgery. The results of two previous meta-analysis showed controversial conclusions regarding the impact of EDA on perioperative survival. The purpose of the present meta-analysis was to evaluate, whether thoracic EDA has the potential to reduce perioperative cardiac morbidity or mortality on the basis of available randomized controlled trials.
A systematic literature search was conducted in medical databases (Med-Line, EBM-Reviews, Embase, Biosis and Biological Abstracts) and relevant clinical trials including patients undergoing noncardiac surgery were evaluated by two independent investigators. All randomized controlled trials investigating the effects of thoracic EDA on perioperative outcome, published from 1980 up to the end of 2008 were included into this quantitative systematic review. Calculations were performed using the statistics program Review Manager 4.1 using a fixed-effects model.
Nine studies with a total of 2,768 patients were included in the meta-analysis. Thoracic EDA did not reduce perioperative mortality [odds ratio (Peto OR): 1.08; 95% confidence interval (CI) 0.74-1.58]. Patients receiving thoracic EDA demonstrated a tendency to a lower rate of perioperative myocardial infarction. However, this effect of thoracic EDA did not reach statistical significance (Peto OR: 0.65; 95% CI 0.4-1.05).
The present meta-analysis did not prove any positive influence of thoracic EDA on perioperative in-hospital mortality in patients undergoing noncardiac surgery. Furthermore, it remains questionable if thoracic EDA has the potential to reduce the rate of perioperative myocardial infarction.
胸段硬膜外镇痛(EDA)被认为可为接受非心脏手术的患者提供心脏保护作用。此前两项荟萃分析的结果显示,关于EDA对围手术期生存率的影响存在相互矛盾的结论。本荟萃分析的目的是基于现有的随机对照试验,评估胸段EDA是否有降低围手术期心脏发病率或死亡率的潜力。
在医学数据库(Med-Line、EBM-Reviews、Embase、Biosis和生物学文摘)中进行了系统的文献检索,两名独立研究人员对包括接受非心脏手术患者的相关临床试验进行了评估。所有调查胸段EDA对围手术期结局影响的随机对照试验,从1980年至2008年底发表的均纳入本定量系统评价。使用统计程序Review Manager 4.1采用固定效应模型进行计算。
荟萃分析纳入了9项研究,共2768例患者。胸段EDA未降低围手术期死亡率[比值比(Peto OR):1.08;95%置信区间(CI)0.74 - 1.58]。接受胸段EDA的患者围手术期心肌梗死发生率有降低趋势。然而,胸段EDA的这种作用未达到统计学显著性(Peto OR:0.65;95% CI 0.4 - 1.05)。
本荟萃分析未证明胸段EDA对接受非心脏手术患者的围手术期院内死亡率有任何积极影响。此外,胸段EDA是否有降低围手术期心肌梗死发生率的潜力仍存在疑问。